2028 ORAL Concomitant versus sequential chemo-radiotherapy for early breast cancer: meta-analysis of randomized clinical trials (RCTs)
Paolo Carlini(National Cancer Institute), Diana Giannarelli(Agostino Gemelli University Polyclinic), Emilio Bria(Università Cattolica del Sacro Cuore), Cecilia Nisticò(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Francesco Cognetti(Apple (Israel)), Fabrizio Ambesi-Impiombato, Paola Papaldo(Cancer Institute (WIA)), Paola Pinnarò, G. Arcangeli, E. Terzoli(Catholic University of America)
Cited by 0
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
|Annals of Oncology|2016|398
Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
|JAMA Oncology|2018|345
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240